Ambuja Cements [AMBUJACEM] vs Vedanta [VEDL] Detailed Stock Comparison
Ambuja Cements
NSE
Loading...
Vedanta
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ambuja Cements wins in 5 metrics, Vedanta wins in 14 metrics, with 0 ties. Vedanta appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ambuja Cements | Vedanta | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.89 | 12.00 | Vedanta |
| Price-to-Book Ratio | 2.66 | 4.22 | Ambuja Cements |
| Debt-to-Equity Ratio | 1.24 | 140.04 | Ambuja Cements |
| PEG Ratio | N/A | -0.74 | N/A |
| EV/EBITDA | 23.31 | 5.77 | Vedanta |
| Profit Margin (TTM) | 11.68% | 9.49% | Ambuja Cements |
| Operating Margin (TTM) | 10.69% | 18.95% | Vedanta |
| EBITDA Margin (TTM) | 10.69% | 18.95% | Vedanta |
| Return on Equity | 6.53% | 27.88% | Vedanta |
| Return on Assets (TTM) | 5.15% | 7.37% | Vedanta |
| Free Cash Flow (TTM) | $-64.50B | $225.57B | Vedanta |
| Dividend Yield | 0.37% | 8.78% | Vedanta |
| 1-Year Return | -8.91% | -1.12% | Vedanta |
| Price-to-Sales Ratio (TTM) | 3.86 | 1.13 | Vedanta |
| Enterprise Value | $1,455.01B | $2,435.94B | Vedanta |
| EV/Revenue Ratio | 3.94 | 1.59 | Vedanta |
| Gross Profit Margin (TTM) | 85.12% | 44.14% | Ambuja Cements |
| Revenue per Share (TTM) | $150 | $394 | Vedanta |
| Earnings per Share (Diluted) | $17.55 | $37.09 | Vedanta |
| Beta (Stock Volatility) | -0.14 | 0.89 | Ambuja Cements |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ambuja Cements vs Vedanta Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ambuja Cements | 0.68% | -2.19% | -6.99% | 1.66% | 22.69% | 7.16% |
| Vedanta | 1.36% | 1.38% | -1.41% | 2.10% | 5.06% | -0.04% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ambuja Cements | -8.91% | 43.27% | 159.45% | 180.03% | 378.76% | 781.82% |
| Vedanta | -1.12% | 64.78% | 244.78% | 360.12% | 39.72% | 1,119.46% |
Performance & Financial Health Analysis: Ambuja Cements vs Vedanta
| Metric | AMBUJACEM | VEDL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.43T | ₹1.74T |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,761,538 | 7,867,399 |
| 90 Day Avg. Volume | 2,264,399 | 5,571,001 |
| Last Close | ₹581.10 | ₹450.30 |
| 52 Week Range | ₹453.05 - ₹643.30 | ₹363.00 - ₹526.95 |
| % from 52W High | -9.67% | -14.55% |
| All-Time High | ₹706.95 (Jul 01, 2024) | ₹526.95 (Dec 16, 2024) |
| % from All-Time High | -17.80% | -14.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.24% | 0.06% |
| Quarterly Earnings Growth | 0.22% | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.09% |
| Operating Margin (TTM) | 0.11% | 0.19% |
| Return on Equity (TTM) | 0.07% | 0.28% |
| Debt to Equity (MRQ) | 1.24 | 140.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹216.97 | ₹105.52 |
| Cash per Share (MRQ) | ₹31.73 | ₹48.04 |
| Operating Cash Flow (TTM) | ₹9.45B | ₹377.30B |
| Levered Free Cash Flow (TTM) | ₹41.67B | ₹149.88B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.37% | 8.78% |
| Last 12-Month Dividend | ₹2.00 | ₹39.50 |
Valuation & Enterprise Metrics Analysis: Ambuja Cements vs Vedanta
| Metric | AMBUJACEM | VEDL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.89 | 12.00 |
| Forward P/E | 34.67 | 9.00 |
| PEG Ratio | N/A | -0.74 |
| Price to Sales (TTM) | 3.86 | 1.13 |
| Price to Book (MRQ) | 2.66 | 4.22 |
| Market Capitalization | ||
| Market Capitalization | ₹1.43T | ₹1.74T |
| Enterprise Value | ₹1.46T | ₹2.44T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.94 | 1.59 |
| Enterprise to EBITDA | 23.31 | 5.77 |
| Risk & Other Metrics | ||
| Beta | -0.14 | 0.89 |
| Book Value per Share (MRQ) | ₹216.97 | ₹105.52 |
Financial Statements Comparison: Ambuja Cements vs Vedanta
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMBUJACEM | VEDL |
|---|---|---|
| Revenue/Sales | ₹102.44B | ₹374.34B |
| Cost of Goods Sold | ₹15.24B | ₹209.12B |
| Gross Profit | ₹87.20B | ₹165.22B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹11.00B | ₹70.94B |
| EBITDA | ₹22.21B | ₹80.79B |
| Pre-Tax Income | ₹13.33B | ₹60.53B |
| Income Tax | ₹3.63B | ₹15.96B |
| Net Income (Profit) | ₹9.70B | ₹44.57B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMBUJACEM | VEDL |
|---|---|---|
| Cash & Equivalents | ₹50.43B | ₹39.93B |
| Total Current Assets | ₹197.10B | ₹517.65B |
| Total Current Liabilities | ₹138.45B | ₹735.75B |
| Long-Term Debt | ₹4.72B | ₹532.83B |
| Total Shareholders Equity | ₹638.11B | ₹537.53B |
| Retained Earnings | ₹145.23B | ₹-247.33B |
| Property, Plant & Equipment | ₹6.95B | ₹1.52T |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMBUJACEM | VEDL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AMBUJACEM | VEDL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,761,538 | 7,867,399 |
| Average Daily Volume (90 Day) | 2,264,399 | 5,571,001 |
| Shares Outstanding | 2.46B | 3.91B |
| Float Shares | 800.29M | 1.62B |
| % Held by Insiders | 0.69% | 0.59% |
| % Held by Institutions | 0.19% | 0.20% |
Dividend Analysis & Yield Comparison: Ambuja Cements vs Vedanta
| Metric | AMBUJACEM | VEDL |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹39.50 |
| Last 12-Month Dividend Yield | 0.37% | 8.78% |
| 3-Year Avg Annual Dividend | ₹2.17 | ₹50.00 |
| 3-Year Avg Dividend Yield | 0.42% | 4.26% |
| 3-Year Total Dividends | ₹6.50 | ₹150.00 |
| Ex-Dividend Date | Jun 13, 2025 | Jun 24, 2025 |